U.S. FDA Approves Eisai's Dayvigo (Lemborexant) for Treatment of Insomnia in Adult Patients
- Written by ACN Newswire - Press Releases
Read more //?#
.
AI is Changing Trademarking Forever
The launch of ChatGPT in 2022 marked a turning point for AI. In three short years, AI has been integrated into everything from our phone cameras to ...
Times Media Australia Launches Times Australia Today
A New National Digital Publication Designed to Make Sense of Modern Australia Sydney, Australia — 26 November 2025 — Times Media Australia today an...
The Future of Ozi.com.au
Ozi.com.au: The New Benchmark in Australian Digital Services In a digital landscape evolving at breakneck speed, Australian businesses are demand...
Brisbane’s brightest recognised: Daniel Mikus and James Rolph win Specialist Services Award at the 2025 Brisbane Young Entrepreneur Awards - again
Young Brisbane entrepreneurs Daniel Mikus and James Rolph, cofounders of MR Group, have been officially crowned winners of the Specialist Services...
Members greenlight merger of Regional Australia Bank and Summerland Bank
Regional Australia Bank and Summerland Bank will proceed with a merger after members approved the move at their Annual General Meetings this week...
DesignStreet marks 27 years with a bold rebrand
In a fast-moving industry defined by continuous disruption, one independent creative agency is proving that longevity and innovation can go hand i...